Constructing Integrative ceRNA Networks and Finding Prognostic Biomarkers in Renal Cell Carcinoma

被引:1
|
作者
Lee, Seokwoo [1 ]
Lee, Wook [1 ]
Ren, Shulei [1 ]
Park, Byungkyu [1 ]
Han, Kyungsook [1 ]
机构
[1] Inha Univ, Dept Comp Engn, Incheon 22212, South Korea
基金
新加坡国家研究基金会;
关键词
Competing endogenous RNA; ceRNA network; renal cell carcinoma; prognostic biomarker; CANCER; EXPRESSION; GENE;
D O I
10.1109/TCBB.2022.3214190
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Inspired by a newly discovered gene regulation mechanism known as competing endogenous RNA (ceRNA) interactions, several computational methods have been proposed to generate ceRNA networks. However, most of these methods have focused on deriving restricted types of ceRNA interactions such as lncRNA-miRNA-mRNA interactions. Competition for miRNA-binding occurs not only between lncRNAs and mRNAs but also between lncRNAs or between mRNAs. Furthermore, a large number of pseudogenes also act as ceRNAs, thereby regulate other genes. In this study, we developed a general method for constructing integrative networks of all possible interactions of ceRNAs in renal cell carcinoma (RCC). From the ceRNA networks we derived potential prognostic biomarkers, each of which is a triplet of two ceRNAs and miRNA (i.e., ceRNA-miRNA-ceRNA). Interestingly, some prognostic ceRNA triplets do not include mRNA at all, and consist of two non-coding RNAs and miRNA, which have been rarely known so far. Comparison of the prognostic ceRNA triplets to known prognostic genes in RCC showed that the triplets have a better predictive power of survival rates than the known prognostic genes. Our approach will help us construct integrative networks of ceRNAs of all types and find new potential prognostic biomarkers in cancer.
引用
收藏
页码:2671 / 2680
页数:10
相关论文
共 50 条
  • [31] Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma
    Garrigos, Carmen
    Espinosa, Marta
    Salinas, Ana
    Osman, Ignacio
    Medina, Rafael
    Taron, Miguel
    Molina-Pinelo, Sonia
    Duran, Ignacio
    ONCOTARGET, 2017, 8 (63) : 106551 - 106564
  • [32] Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Harris, Wayne B.
    Kucuk, Omer
    Carthon, Bradley C.
    Gillespie, Theresa W.
    Master, Viraj A.
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2017, 97 : 229A - 229A
  • [33] Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma
    Tao, Hongmiao
    Li, Zeyu
    Mei, Yuan
    Li, Xiaoling
    Lou, Hongqiang
    Dong, Lihua
    Zhou, Liangcheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [34] The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
    Kang, Weiting
    Zhang, Meng
    Wang, Qiang
    Gu, Da
    Huang, Zhilong
    Wang, Hanbo
    Xiang, Yuzhu
    Xia, Qinghua
    Cui, Zilian
    Jin, Xunbo
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [35] GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
    Yao, Lei
    Li, Juanni
    Xu, Zhijie
    Yan, Yuanliang
    Hu, Kuan
    AGING-US, 2022, 14 (06): : 2758 - 2774
  • [36] Biomarkers in renal cell carcinoma
    Terzic, Jasmin
    Bauernhofer, Thomas
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (04) : 342 - 346
  • [37] Biomarkers of renal cell carcinoma
    Ngo, Tin C.
    Wood, Christopher G.
    Karam, Jose A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (03) : 243 - 251
  • [38] Biomarkers in renal cell carcinoma
    McGuire, Barry B.
    Fitzpatrick, John M.
    CURRENT OPINION IN UROLOGY, 2009, 19 (05) : 441 - 446
  • [39] Biomarkers in renal cell carcinoma
    Jasmin Terzic
    Thomas Bauernhofer
    memo - Magazine of European Medical Oncology, 2019, 12 : 342 - 346
  • [40] Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma
    Wang, Yu
    Sun, Zhuolun
    Lu, Shuo
    Zhang, Xu
    Xiao, Chutian
    Li, Tengcheng
    Wu, Jieying
    FRONTIERS IN ONCOLOGY, 2022, 12